logo

Meridian Bioscience :Trading Transparency
By: Bobs Advice for Stocks   Thursday, July 17, 2008 4:48 PM

Vote for next session
The next market session will close:

Every once in awhile I just break all of my rules.  (And I usually regret it as well!

I wanted to report on my latest indiscretion.  Meridian (VIVO) a holding of mine reported today.  Latest sales for the third quarter increased 11%.  EPS came in at $.19/share, down from $.22/share, but last year included a tax benefit of $2.4 million.  Taking this out it worked out to $.19/share this year vs. $.16/share a year ago.

Anyhow, the market has absolutely taken this stock apart.

Daring to go into the jaws of this awful negative momentum, I purchased 2,000 shares of VIVO a few moments ago at an average cost of $23.99/share.  As I write, VIVO has already slipped BELOW this price, currently trading at $23.81/share, down $(4.93) or (17.15)% on the day.

I think this is way overdone.

I am trying to think rationally in the face of apparent market madness.

That can be a recipe for failure for me.  But I shall put my contrarian hat on, hold my nose, and keep you posted.

Wish me luck.

And probably wish me better discipline at following my own rules.  I guess that is what defines me as an amateur after all.

And I did it on margin :(.

 

Bob 


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Bobs Advice for Stocks



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia